An Investing Tip From A Legend

Join TradeAlgo's Free Live Trading Session ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ [EARN WHILE YOU LEARN! JOIN OUR FREE LIVE TRADING SESSION!]( Hello investor, An Investing Tip From A Legend Stan Druckenmiller has an investing track record that can match virtually anybody – including Warren Buffett. His hedge fund, Duquesne Capital, delivered an annual average return of 30% for almost four decades from 1986 to 2010. And he never had a down year. He was featured in David Rubenstein’s new book called How to Invest. We will highlight his number one tip on investing that can be extraordinarily beneficial to you as a retail investor. Stan Druckenmiller His #1 tip on investing: Rubenstein asked him what the qualities of great investors were. Druckenmiller pointed to a lesson he learned from George Soros, whom he previously worked for. It’s not whether you are right or wrong. Rather, it is how much you make when you are right… and… how much you will lose when you’re wrong. And once you’re convinced about something, go big. He pointed to legendary investors like Warren Buffett, Carl Icahn, and George Soros as someone who go big when they’re convinced about something. Warren Buffett is known as a conservative investor, but Apple makes up nearly 41% of his portfolio. - “If you think about it, whether it’s Warren Buffett, Carl Icahn, or George Soros, almost every great investor is a big concentrator above what they would ever teach in business school. It was sizing of positions that I learned from George,” said Stan Druckenmiller. And there was another tip in that paragraph – “…above what they would ever teach in business school.” A business school teaches what’s average. But no extraordinary success can be achieved by following the average. Rather, a retail investor may be better off learning from actual players in finance who have achieved what the investor aspires to do. Top Med-Tech Stock With Big Growth Story Today’s Stock Pick: Natera, Inc. (NTRA) Natera is a DNA testing company that operates in an large, underpenetrated markets. What it does is simple. It tests blood to screen for fetal genetic abnormalities (such as Down syndrome). The non-invasive reproductive health segment has grown rapidly in every year since 2013. There were about 88,000 tests in 2013, and the number jumped to over 1 million in 2020. More and more well-respected organizations recommend screenings. The American College of Obstetricians and Gynecologists reaffirmed its recommend for chromosomal defect screening for all women in August 2020. So, many insurers will reimburse for the test with over 90% of all commercially covered patients are eligible for Natera’s Panorama test. As you can see, Natera operates in a rapidly-growing market. The company is considered as the leader in this market and have added several segments to test for — oncology, women’s health and organ health. (Source: Natera) Right now, the company has over 400 issued or pending patents. Over 10 million tests were processed for 12 products. (Source: Natera) As a result, Natera has one of the best growth stories in the stock market. Lookin gat year on year trend for the fourth quarter, it grew its revenue by about 80% in just two years — going from $173 million to $311 million. (Source: Natera) More importantly, the company is reducing its cash burn quarterly. Natera expects to be break even in the third quarter which can be a powerful catalyst for its stock price. Wall Street likes to buy stocks that just turned profitable and growing at a rapid pace. (Source: Natera) Adding the fuel to its growth story is expanding gross margin. Natera posted a full-year gross margin of 45.5% for 2023. (That was above the estimates.) Now it expects between 50% and 53% gross margin for 2024 — or a growth of 13% at the midpoint. The guidance for total revenue is between $1.32 billion. and $1.35 billion. That would be about 25% revenue growth. (Source: Natera) Bottom line: Natera operates in a fast-growing market that looks unstoppable. Keep in mind that it is priced as a growth stock. It offers more risk (but with potentially more upside) than your regular blue-chip stock. If you are looking to add a growth stock, this is the one to pay attention to. [EARN WHILE YOU LEARN! JOIN OUR FREE LIVE TRADING SESSION!](       © All Rights Reserved, Trade Alliance [Unsubscribe]( | [Manage Preferences](